Published July 2022
Over the last two decades, the combination of demographic trends and social-cultural dynamics continue to drive outside investor interest within the women’s health sector. Experts project the global $32.8B industry to reach $45.5B by 2028 (2021-2028 CAGR of 4.8%), leading to heightened attraction from new investors and amplified competition among sponsors already invested in the space.
While the genesis of women’s health investment started almost 10 years ago, 90+ transactions occurred since the start of 2020, representing roughly 65% of deal volume over the last five years. Since 2015, approximately 10 organizations moved on to their second private equity partner, with ~33% of sponsors over three years into their initial platform investment.
Given the current landscape, Provident expects to see continued transaction activity as it relates to new platform investments, secondary buyouts, and add-on acquisitions. Additionally, the adoption of value-based care arrangements will presumably boost activity from larger health systems or diversified platforms looking to build integrated care models.
In this white paper, we examine the evolution of investment activity within the women’s health space as well as go-forward expectations for the sector. We will also cover key topics such as valuation expectations, partnership considerations, and private equity’s impact on women’s health.
- Surveying the Women’s Health Services Landscape
- Women’s Health Subspecialties
- Moving Toward the Next Phase of its Investment Life Cycle
- Private Equity Investment’s Impact on the Women’s Health Space
- Partnership Considerations
- Provident Case Studies
- Current Valuation Landscape
- Select Private Equity Transactions